Rudy Li
Stock Analyst at Chardan Capital
(n/a)
# 4,691
Out of 4,784 analysts
8
Total ratings
n/a
Success rate
-24.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $7.21 | +232.87% | 3 | Mar 19, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $40 | $13.14 | +204.41% | 3 | Feb 21, 2025 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | $20 | $6.19 | +223.10% | 2 | Dec 20, 2024 |
Stoke Therapeutics
Mar 19, 2025
Maintains: Buy
Price Target: $24
Current: $7.21
Upside: +232.87%
Prothena Corporation
Feb 21, 2025
Maintains: Buy
Price Target: $40
Current: $13.14
Upside: +204.41%
Mind Medicine (MindMed)
Dec 20, 2024
Initiates: Buy
Price Target: $20
Current: $6.19
Upside: +223.10%